Compare
Pit 2–4 stocks against each other: U-Score, pillars, fundamentals, and normalized price history. Same universe, same methodology, one view.
| Metric | AKUMS Akums Drugs and Pharmaceuticals Limited Pharma · Large | ANTHEM Anthem Biosciences Limited Pharma · Large | AARTIPHARM Aarti Pharmalabs Limited Pharma · Micro | SYNGENE Syngene International Limited Pharma · Small |
|---|---|---|---|---|
| Final Score | 45 | 51 | 35 | 29 |
| Verdict | WATCHLIST | FAIR VALUE | WATCHLIST | OVERVALUED |
| Style | Financial Turnaround | Premium Compounder | WATCHLIST | OVERVALUED |
| Piotroski | 8/9 | 8/9 | 8/9 | 8/9 |
| Valuation | 7/30 | 0/30 | 7/30 | 2/30 |
| Growth | 15/25 | 14/25 | 12/25 | 7/25 |
| Quality | 1/20 | 17/20 | 0/20 | 0/20 |
| Balance Sheet | 12/15 | 11/15 | 8/15 | 11/15 |
| Cash Flow | 5/10 | 4/10 | 2/10 | 4/10 |
| Price | ₹544.45 | ₹775 | ₹625.25 | ₹444.3 |
| P/E | 32.00 | 71.40 | 31.10 | 48.30 |
| P/B | 2.58 | 14.26 | 2.59 | 3.75 |
| ROE | 8.45% | 22.30% | 8.59% | 7.86% |
| ROCE | 14.90% | 30.40% | 10.70% | 10.10% |
| Debt / Equity | 0.05 | 0.02 | 0.43 | 0.09 |
| FCF Yield | 2.92% | 0.33% | — | 0.30% |
| Dividend Y | 0.18% | 0.26% | 0.82% | 0.28% |
| Altman Z | 4.59 | 8.94 | 3.65 | 7.00 |
| Promoter % | 75.26% | 74.67% | 43.08% | 52.68% |
| Mkt Cap (₹Cr) | 8582.00 | 43515.00 | 5497.00 | 18147.00 |
| Graham # | ₹277.41 | ₹113.37 | ₹318.52 | ₹145.68 |
| Fair PE | 42.0 | 42.0 | 42.0 | 8.3 |
| MoS % | +20.0% | -75.1% | +22.7% | -581.9% |
Normalized price (3-year, indexed to 100)
Higher line = better relative performance from startAKUMS69
ANTHEM103
AARTIPHARM95
SYNGENE49